Influence of CYP2D6 , CYP2C19 , and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish Patients.
Saved in:
| Title: | Influence of CYP2D6 , CYP2C19 , and CYP2C9 Pharmacogenetics and Clinical Factors on Dose-Normalized Venlafaxine/O-Desmethylvenlafaxine Metabolic Ratio in Spanish Patients. |
|---|---|
| Authors: | Thomas, Levin1,2 (AUTHOR), de la Cruz, Carla González1,2 (AUTHOR), Mata-Martín, Carmen1,2,3 (AUTHOR), González-Rodríguez, Idian1,3,4 (AUTHOR), González-Martínez, Idilio1,4 (AUTHOR), Peñas-Lledó, Eva M.1,2 (AUTHOR), LLerena, Adrián1,2,3 (AUTHOR) allerena@unex.es |
| Source: | Pharmaceuticals (14248247). Feb2026, Vol. 19 Issue 2, p209. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
